Discover
GLSI
Greenwich LifeSciences, Inc.
23.70
2 x 17.36
2 x 29.79
bid
ask
+
0.24
1.02%
2 @ 06:03 AM
23.03 -0.67 (2.81%)
| Ytd | 12.80% | |
| 1y | 161.88% |
22.86
day range
24.50
7.78
52 week range
34.10
| Open | 23.51 | Prev Close | 23.46 | Low | 22.86 | High | 24.50 | Mkt Cap | 347.87M |
| Vol | 84.79K | Avg Vol | 141.89K | EPS | -1.61 | P/E | N/A | Forward P/E | -14.83 |
| Beta | 3.32 | Short Ratio | 21.41 | Inst. Own | 8.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 24.15 | 200-d Avg | 19.64 | 1yr Est | 38.00 |
GLSI News
benzinga.com
Greenwich LifeSciences Q4 EPS $(0.58) Misses $(0.31) Estimate
Greenwich LifeSciences (NASDAQ:GLSI) reported quarterly losses of $(0.58) per share which missed the
benzinga.com
Greenwich LifeSciences Announces Published Abstract And Poster On Its Phase III FLAMINGO-01 Trial Fo
from the ASCO Annual Meeting 2026.The abstract is shown below and the poster being presented today c
benzinga.com
Greenwich LifeSciences Reports Progress in Late-Stage Breast Cancer Immunotherapy Trial
Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutic